ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
11.81
-0.18 (-1.50%)
Oct 12, 2026, 4:00 PM EDT - Market closed
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $1.22 billion as of October 12, 2026. It is the 9,118th most valuable company in the world and the 2,112th biggest in the United States. Its market cap has decreased by 7.87% in one year.
Market Cap
1.22B
Enterprise Value
965.37M
1-Year Change
-7.87%
Global Rank
Country Rank
#2,112 United States
Category
ChartMarket Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $1.22B, an increase of 64.98%. That is a compound annual growth rate of 8.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 1.22B | 53.66% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alpha Tau Medical | 1.33B |
| Ascentage Pharma Group International | 1.32B |
| Damora Therapeutics | 1.30B |
| Replimune Group | 1.26B |
| Savara | 1.25B |
| Nanobiotix | 1.21B |
| LB Pharmaceuticals | 1.20B |
| Vor Biopharma | 1.18B |